# Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation

> **NCT02189824** · PHASE1 · UNKNOWN · sponsor: **University of Sydney** · enrollment: 12 (estimated)

## Conditions studied

- Acute Myeloid Leukaemia

## Interventions

- **BIOLOGICAL:** Partially HLA-matched unrelated donor cells

## Key facts

- **NCT ID:** NCT02189824
- **Lead sponsor:** University of Sydney
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2015-11-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189824, "Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02189824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*